Skip to main content

Closed

REGN: Regeneron Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

79thpctl

Volume

1.12×avg

Market Cap

78.57BUSD

P/E Ratio

18.2TTM

Div Yield

0.48%ann

Regeneron Pharmaceuticals, Inc.

REGNNASDAQ Global Select·USD·Closed

Regeneron Pharmaceuticals, Inc.

REGNNASDAQ·USD·Closed

$762.63

+3.29%

$762.63

+$24.29 (3.29%)

52W Range

79thpctl

Volume

1.12×avg

Mkt Cap

78.57BUSD

P/E

18.2TTM

Div Yield

0.48%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings